Drug Shortage Report for M-M-R II
Report ID | 4420 |
Drug Identification Number | 00466085 |
Brand name | M-M-R II |
Common or Proper name | (measles, mumps and rubella virus vaccine, live, attenuated) Lyophilized powder for injection |
Company Name | MERCK CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | MEASLES VIRUS VACCINE LIVE ATTENUATED; MUMPS VIRUS VACCINE LIVE ATTENUATED (JERYL LYNN STRAIN); RUBELLA VIRUS VACCINE LIVE ATTENUATED (WISTAR RA27/3 STRAIN) |
Strength(s) | 0.5 mL dose after reconstitution Measles: ≥1000 CCID50 Mumps: ≥5000 CCID50 Rubella: ≥1000 CCID50 |
Dosage form(s) | Powder For Solution |
Route of administration | Subcutaneous |
Packaging size | 10x1dose |
ATC code | J07BD |
ATC description | VIRAL VACCINES |
Reason for shortage | Requirements related to complying with good manufacturing practices. |
Anticipated start date | 2017-05-10 |
Actual start date | 2017-05-11 |
Estimated end date | 2017-05-20 |
Actual end date | 2017-05-12 |
Shortage status | Resolved |
Updated date | 2017-05-15 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 16750 ROUTE TRANSCANADIENNE KIRKLAND, QUEBEC CANADA H9H 4M7 |
Company contact information | 1-800-567-2594 medinfocanada@merck.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v15 | 2017-05-15 | French | Compare |
v14 | 2017-05-15 | English | Compare |
v13 | 2017-05-12 | English | Compare |
v12 | 2017-05-11 | English | Compare |
v11 | 2017-05-11 | English | Compare |
v10 | 2017-05-05 | English | Compare |
v9 | 2017-05-02 | English | Compare |
v8 | 2017-04-10 | English | Compare |
v7 | 2017-04-10 | French | Compare |
v6 | 2017-04-10 | French | Compare |
v5 | 2017-04-10 | English | Compare |
v4 | 2017-03-27 | French | Compare |
v3 | 2017-03-27 | English | Compare |
v2 | 2017-03-27 | English | Compare |
v1 | 2017-03-27 | English | Compare |
Showing 1 to 15 of 15